JUNE 2009

 
World-class news and data direct to your iPhone, iPod or BlackBerry
The new Thomson Reuters mobile news application delivers much more than headlines—and it's free!
FULL STORY>

Put your research on the map with Intelligent Information for Life
Thomson Reuters customers are applying intelligent information to tackle the challenges of the world—see our innovation map and hear some of their stories.
FULL STORY>

A new set of rules for innovation
In tough economic times, forward-thinking IP leaders need to establish their own change management initiative such that corporate strategy is shaped (and in some cases dictated) through a company's investments.
FULL STORY>

Influenza A (H1N1) and the threat of pandemic
Download our free disease briefing on influenza, and access further detailed sources of information.
FULL STORY>

Swine influenza - lessons from history identified by Web of Science
With 110 years of coverage of international scholarly journals, Web of Science can identify highly valuable research relating to influenza.
FULL STORY>

The problem with cancer
Dr Jeffrey Ross talks about his research focusing on identifying biomarkers in breast and prostate cancer—and whether cancer screening could do more harm than good in some cases.
FULL STORY>

Thought leaders in the unthinkable
Science Watch examines highly cited research on bioterrorism over the last decade.
FULL STORY>

InCites - charting research performance
Information Today's Barbara Brynko interviewed Jim Pringle about InCites, a customized, citation-based research analytics tool that enables you to evaluate and benchmark your institutional productivity.
FULL STORY>

Scholarly R&D: coping with cuts
It's inevitable there are going to be cuts in research funding. But even in the downturn, there are success stories for those who are prepared to show evidence of value.
FULL STORY>

Journal Citation Reports 2008 – more titles, new metrics
Register now for free web-based training to help keep you up to date and take advantage of new functionality in Journal Citation Reports.
FULL STORY>

Asian innovation takes hold in the US
The Thomson Reuters 2008 Global Innovation Study revealed that Asian innovation is taking hold in the US.
FULL STORY>

HIV pathogenesis - is a vaccine possible?
Webcast by Françoise Barré-Sinoussi, winner of the 2008 Nobel Prize in Medicine, on the current and future state of HIV research.
FULL STORY>

Building a benefit-risk framework for new medicines
The CMR International Institute for Regulatory Science has made significant advances in outlining a common framework for the assessment of the benefits and risks of new medicines.
FULL STORY>

Can intelligent cuts in drug R&D ease the pain?
When stock plunges, drug discovery budgets shrink. Survival is all about making the right go, no-go decisions as early as possible.
FULL STORY>

Parasites – disease or delight?
Biologists have increasingly understood that parasites are part of a fully functional living world and if removed, the infrastructure of our planet would be drastically altered.
FULL STORY>

Metrics-based research evaluation
The challenges in building robust research evaluation and management systems in institutions can be best overcome by the research management and librarian community working together.
FULL STORY>

Open standards and accurate author identification – join the debate
New Community Forums for ResearcherID include some lively exchanges around author identification.
FULL STORY>

Protecting a nation from drug disasters
Medical oncologist Professor Masanori Fukushima aims to translate Japan's highly regarded life sciences research into clinical practice for the benefit of practitioners and ultimately patients.
FULL STORY>

Race against time - building on past research to contain H1N1
Scientists and national policy makers rely on scientific literature to develop a fundamental understanding of the H1N1 virus and to expedite the development of antiviral drugs and vaccines.
FULL STORY>

Join our IP seminar in Tokyo
Join industry leaders for a seminar and panel discussion on the innovation crisis, exclusively for intellectual property professionals.
FULL STORY>